| 0 (0%) | 01-19 18:50 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 10.78 | 1-year : | 11.18 |
| Resists | First : | 9.23 | Second : | 9.57 |
| Pivot price | 9.19 |
|||
| Supports | First : | 8.68 | Second : | 7.23 |
| MAs | MA(5) : | 9 |
MA(20) : | 9.15 |
| MA(100) : | 9.29 |
MA(250) : | 8.71  |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 29.2 |
D(3) : | 29.4 |
| RSI | RSI(14): 44.7 |
|||
| 52-week | High : | 11.14 | Low : | 6.19 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ GRFS ] has closed above bottom band by 10.4%. Bollinger Bands are 2.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 9.09 - 9.14 | 9.14 - 9.2 |
| Low: | 8.68 - 8.73 | 8.73 - 8.79 |
| Close: | 8.78 - 8.88 | 8.88 - 8.99 |
Wed, 14 Jan 2026
Grifols (NASDAQ:GRFS) Shares Gap Up - What's Next? - MarketBeat
Wed, 14 Jan 2026
Grifols achieves EMA certification for Egyptian plasma operations - MSN
Mon, 12 Jan 2026
Grifols, S.A. (GRFS) Stock Analysis: Exploring An 18.46% Upside In The Healthcare Sector - DirectorsTalk Interviews
Mon, 12 Jan 2026
Grifols, S.A. (NASDAQ:GRFS) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Sun, 11 Jan 2026
(GRFS) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Mon, 08 Dec 2025
Grifols: Positive/Neutral Scenario Posits An Upside (NASDAQ:GRFS) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 258 (M) |
| Shares Float | 535 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 56.5 (%) |
| Shares Short | 6,650 (K) |
| Shares Short P.Month | 5,110 (K) |
| EPS | 0.63 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.93 |
| Profit Margin | 4.9 % |
| Operating Margin | 20.4 % |
| Return on Assets (ttm) | 4.5 % |
| Return on Equity (ttm) | 5.8 % |
| Qtrly Rev. Growth | 4 % |
| Gross Profit (p.s.) | 11.61 |
| Sales Per Share | 29.12 |
| EBITDA (p.s.) | 6.77 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1,130 (M) |
| Levered Free Cash Flow | 778 (M) |
| PE Ratio | 13.89 |
| PEG Ratio | 0 |
| Price to Book value | 0.99 |
| Price to Sales | 0.3 |
| Price to Cash Flow | 2.03 |
| Dividend | 0.17 |
| Forward Dividend | 0 |
| Dividend Yield | 1.9% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|